Literature DB >> 27910252

Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.

Jong-Hwan Park1, Hyuntae Park1,2, Sang Wuk Sohn3, Sungjae Kim4, Kyung Won Park1,3,5.   

Abstract

AIM: To determine the factors that influence diagnosis and differentiation of patients with mild cognitive impairment (MCI) and Alzheimer's dementia (AD) by comparing memory test results at baseline with those at 1-2-year follow up.
METHODS: We consecutively recruited 23 healthy participants, 44 MCI patients and 27 patients with very mild AD according to the National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorder Association criteria for probable Alzheimer's disease and Petersen's clinical diagnostic criteria. We carried out detailed neuropsychological tests, including the Story Recall Test (SRT) and the Seoul Verbal Learning Test, for all participants. We defined study participants as the "progression group" as follows: (i) participants who showed conversion to dementia from the MCI state; and (ii) those with dementia who showed more than a three-point decrement in their Mini-Mental State Examination scores with accompanying functional decline from baseline status, which were ascertained by physician's clinical judgment.
RESULTS: The SRT delayed recall scores were significantly lower in the patients with mild AD than in those with MCI and after progression. Lower (relative risk 1.1, 95% confidence interval 0.1-1.6) and higher SRT delayed recall scores (relative risk 2.1, confidence interval 1.0-2.8), and two-test combined immediate and delayed recall scores (relative risk 2.0, confidence interval 0.9-2.3; and relative risk 2.8, confidence interval 1.1-4.2, respectively) were independent predictors of progression in a stepwise multiple adjusted Cox proportional hazards model, with age, sex, depression and educational level forced into the model.
CONCLUSIONS: The present study suggests that the SRT delayed recall score independently predicts progression to dementia in patients with MCI. Geriatr Gerontol Int 2017; 17: 1603-1609.
© 2016 Japan Geriatrics Society.

Entities:  

Keywords:  Story Recall test; cognitive function; dementia; mild cognitive impairment; verbal memory

Mesh:

Year:  2016        PMID: 27910252     DOI: 10.1111/ggi.12940

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  5 in total

1.  Multi-Component Intervention Program on Habitual Physical Activity Parameters and Cognitive Function in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial.

Authors:  Min-Ki Jeong; Kyung-Won Park; Je-Kwang Ryu; Gwon-Min Kim; Hyun-Hun Jung; Hyuntae Park
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

2.  Association Between Carotid Artery Intima-Media Thickness and Combinations of Mild Cognitive Impairment and Pre-Frailty in Older Adults.

Authors:  Jinkee Park; Jong-Hwan Park; Hyuntae Park
Journal:  Int J Environ Res Public Health       Date:  2019-08-19       Impact factor: 3.390

3.  Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.

Authors:  Hee-Yeon Shin; Ha-Ri Kim; Geon-Ho Jahng; Chul Jin; Seungwon Kwon; Seung-Yeon Cho; Seong-Uk Park; Woo-Sang Jung; Sang-Kwan Moon; Chang-Nam Ko; Jung-Mi Park
Journal:  BMC Complement Med Ther       Date:  2021-10-07

4.  Functional Integrity of Executive Control Network Contributed to Retained Executive Abilities in Mild Cognitive Impairment.

Authors:  Wan Liu; Li Liu; Xinxin Cheng; Honglin Ge; Guanjie Hu; Chen Xue; Wenzhang Qi; Wenwen Xu; Shanshan Chen; Run Gao; Jiang Rao; Jiu Chen
Journal:  Front Aging Neurosci       Date:  2021-11-26       Impact factor: 5.750

5.  The Effect of Clinical Characteristics and Subtypes on Amyloid Positivity in Patients with Amnestic Mild Cognitive Impairment.

Authors:  Jeong Yeon Kim; Jun Ho Lim; Young Jin Jeong; Do-Young Kang; Kyung Won Park
Journal:  Dement Neurocogn Disord       Date:  2019-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.